Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis.
Häggström I, Leithner D, Alvén J, Campanella G, Abusamra M, Zhang H, Chhabra S, Beer L, Haug A, Salles G, Raderer M, Staber PB, Becker A, Hricak H, Fuchs TJ, Schöder H, Mayerhoefer ME. Häggström I, et al. Among authors: schoder h. Lancet Digit Health. 2024 Feb;6(2):e114-e125. doi: 10.1016/S2589-7500(23)00203-0. Epub 2023 Dec 21. Lancet Digit Health. 2024. PMID: 38135556 Free PMC article.
Advances in oncologic imaging: update on 5 common cancers.
Akin O, Brennan SB, Dershaw DD, Ginsberg MS, Gollub MJ, Schöder H, Panicek DM, Hricak H. Akin O, et al. Among authors: schoder h. CA Cancer J Clin. 2012 Nov-Dec;62(6):364-93. doi: 10.3322/caac.21156. Epub 2012 Oct 15. CA Cancer J Clin. 2012. PMID: 23070605 Free article. Review.
Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration.
Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H. Vargas HA, et al. Among authors: schoder h. Int J Gynecol Cancer. 2013 Oct;23(8):1512-9. doi: 10.1097/IGC.0b013e3182a41e61. Int J Gynecol Cancer. 2013. PMID: 24257566
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.
Moskowitz AJ, Schöder H, Yahalom J, McCall SJ, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz S, Kobos R, Kumar A, Matasar M, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Shukla N, Steinherz P, Straus D, Trippett T, Younes A, Zelenetz A, Moskowitz CH. Moskowitz AJ, et al. Among authors: schoder h. Lancet Oncol. 2015 Mar;16(3):284-92. doi: 10.1016/S1470-2045(15)70013-6. Epub 2015 Feb 13. Lancet Oncol. 2015. PMID: 25683846 Clinical Trial.
336 results